Karam Sammy 4
4 · ABBOTT LABORATORIES · Filed Aug 19, 2021
Insider Transaction Report
Form 4
Karam Sammy
Senior Vice President
Transactions
- Exercise/Conversion
Common shares without par value
2021-08-17$75.90/sh+8,000$607,200→ 30,926 total - Sale
Common shares without par value
2021-08-17$125.00/sh−8,000$1,000,000→ 22,926 total - Exercise/Conversion
Option (right to buy)
2021-08-17−8,000→ 56,978 totalExercise: $75.90From: 2020-02-22Exp: 2029-02-21→ Common Shares (8,000 underlying)
Footnotes (1)
- [F1]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.